211.1. A.K. Goyal| Link| Bookmark|
February 16, 2024 8:46:38 AM
Top Contributor (200+ Posts, 100+ Likes)
1228.7 ON NSE
210. whiteFox| Link| Bookmark|
February 16, 2024 8:45:20 AM
IPO Mentor (600+ Posts, 200+ Likes)
1245
209. whiteFox| Link| Bookmark|
February 16, 2024 7:03:02 AM
IPO Mentor (600+ Posts, 200+ Likes)
Listing around 1200. Buy only below 1000.
208. Unknown Man| Link| Bookmark|
February 16, 2024 1:07:48 AM
Top Contributor (300+ Posts, 100+ Likes)
Listing discount ho toh ghabrana nahi hai...
Let the dust settle...
This is a long term portfolio story.
Healthcare distributorship is fragmented and organized.. but with the regulatory tightening.. and economies of scale.. large nations nal players like Entero is likely to benefit. The total addressable market is huge.. and they have penetrated only a small market share this far...
If the management remains determined.. they can grow tremendously. Something to be tracked in during the concalls in future..
My plan: Hold and add when I see opportunity.
207. Unknown Man| Link| Bookmark|
February 15, 2024 11:59:15 PM
Top Contributor (300+ Posts, 100+ Likes)
Chalo RHP padhte Hain ab.
207.1. Unknown Man| Link| Bookmark|
February 16, 2024 1:03:17 AM
Top Contributor (300+ Posts, 100+ Likes)
Very interesting company...
Orbimed is the promoter ..which is one of the largest PE in healthcare portfolio.
Remember when orbimed invested in Marksans..the stock went from 40--> 130
They have huge expertise in healthcare domain. Sujesh Vasudevan ..chairman is also a director in Eris life sciences..
Just look at the scale and skills they have.
Orbimed and other promoters and non promoter groups are selling ..but very small quantity compared to what they have.
206. Unknown Man| Link| Bookmark|
February 15, 2024 7:07:01 PM
Top Contributor (300+ Posts, 100+ Likes)
Sochne wali baat hai ki when nobody wants this...why anchor have invested in this.
With the govt push to increase medical devices manufacturing.. this company should benefit in the medium to long term.
GMP or no GMP... Company has shown capability to scale with pan India presence...and soon it may give better profitability as well.
Healthcare still very under penetrated and lot of money coming to India for healthcare services, products, hospitals..etc... Entero is a good proxy to that.
I plan to hold...and further add on dips.
My earlier bet on medi assist has been good so far. I will plan to trim that position a little in the next upmove..
206.1. UjwalG| Link| Bookmark|
February 15, 2024 7:15:07 PM
IPO Guru (1000+ Posts, 500+ Likes)
Can you tell me, out of 60000+ SKUs how much percentage are medical devices ?
206.2. Unknown Man| Link| Bookmark|
February 16, 2024 12:58:13 AM
Top Contributor (300+ Posts, 100+ Likes)
Why focus on just medical devices.. they are largely a distributor of all healthcare needs.. think of optionalities...
1. Acquire more local players 2. Increase product offering 3. Increase client network.. no dearth of hospitals, pharmacies and clinics and pharma companies, device manufacturing companies.. recently added Roche for glucose monitor device for home....
4. Private label ..make and sell their own products
Everything they are already doing.
205. KarmaTheLord| Link| Bookmark|
February 15, 2024 11:52:59 PM
Top Contributor (200+ Posts, 100+ Likes)
Got 2/3 in Retail All applications were 3rd party, one rejected two got allotment (don't know how they decide !!!).
BOA is out More than 85% shares are allotted to institutions, There will be very minimal supply from Retail and HNI to be absorbed tomorrow. Sticking my neck out and saying, this will not list negative (although not expecting too high listing gains either) My expectations - Listing at 0% to 5% premium.